April 20, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The rate of insomnia in the United States has more than doubled […]
April 20, 2021
Results from a 1-year, open-label safety study suggest that the oral migraine prevention drug rimegepant is safe and effective in patients with cardiovascular risk factors. Patients […]
April 19, 2021
For women with multiple sclerosis (MS), results of MRI performed during the year before they become pregnant appear to accurately predict early relapse after childbirth, new […]
April 19, 2021
Intranasal zavegepant, a third-generation calcitonin gene-related peptide (CGRP) receptor agonist, is effective and well tolerated in the treatment of acute migraine, new research shows. In a […]
April 18, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two new large international studies have found relatively low rates of stroke […]
April 17, 2021
Black patients with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) may respond differently to common MS treatment compared to their White peers, new research […]
April 15, 2021
Individuals with multiple sclerosis (MS) seek additional acute medical care during periods of unusually warm weather, a new study has found, raising concerns about possible increased […]
April 15, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. About half of children with pediatric inflammatory multisystem syndrome temporally associated with […]
April 15, 2021
Cardiologists experienced in cardiac interventions can competently perform stroke thrombectomy after a short period of training, with comparable outcomes to those achieved by neuroradiology centers, a […]